Pzena Investment Management recently released its fourth-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The fourth quarter was defined by ...
Q4 2025 Sales: $1.08 billion, a decline of 11% year-over-year. Q4 2025 Adjusted EBITDA: $280 million, a decline of 17% versus the prior year quarter. Q4 2025 Adjusted EPS: $1.20, a 33% decline due to ...
FMC Corp. (FMC) said its board has authorized the exploration of strategic alternatives, including the sale of the company. The strategic review is at a preliminary stage, and there can be no ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A sale could add a new name to ...
FMC missed on revenue but met adjusted earnings expectations in the fourth quarter. Management's 2026 guidance called for more revenue and profit declines. The Board of Directors also authorized a ...
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results